Novo Holdings acquires blow-fill-seal manufacturing specialist Ritedose 10-Jan-2022 By Jane Byrne Life science investor group, Novo Holdings, has agreed to buy Ritedose, the largest sterile CDMO in the US focused on advanced blow-fill-seal technology, from Hong-Kong based, AGIC Capital, and China’s Humanwell.